The RAS/MAPK Syndromes Homepage

The RAS/mitogen activated protein kinase (MAPK) pathway is implicated in growth-factor mediated cell proliferation, differentiation and cell death Recent studies have revealed dysregulation of the RAS/MAPK cascade to be the common molecular basis for congenital multiple anomaly/mental retardation syndromes: Noonan syndrome, LEOPARD syndrome, Costello syndrome and CFC syndrome. Neurofibromatosis type I , which is caused by loss-of-function mutations of NF1, can also be included in the same disease entity, while patients with NF1 are not usually associated with facial dysmorphisms or cardiac anomaly. We suggest that ġNoonan syndrome, LEOPARD syndrome, Costello syndrome, CFC syndrome, and neurofibromatosis type I may be comprehensively termed the RAS/MAPK syndromes.

What is the RAS/MAPK pathway?
The RAS/MAPK syndromes overview
Genes and disorders with germline mutations and somatic mutations overview
Disorders with germline mutations
  • Costello s yndrome
  • CFC (cardio-facio-cutaneous) syndrome
  • Noonan syndrome
Mutation database
Mutation database is under construction and Excel Tables are now available.